S&P 500   3,383.76 (+0.10%)
DOW   27,930.43 (-0.17%)
QQQ   274.36 (+0.92%)
AAPL   461.35 (+2.06%)
MSFT   210.71 (+0.73%)
FB   263.90 (+1.54%)
GOOGL   1,529.61 (+1.48%)
AMZN   3,207.98 (+1.45%)
NVDA   462.34 (+1.03%)
CGC   17.27 (+0.12%)
BABA   255.36 (+0.07%)
TSLA   1,639.00 (+5.42%)
GE   6.61 (-1.64%)
MU   46.79 (-3.49%)
AMD   82.50 (-0.13%)
T   29.97 (-0.70%)
F   7.10 (-0.14%)
ACB   10.00 (+2.04%)
GILD   68.06 (-1.13%)
NFLX   481.66 (+1.30%)
DIS   131.56 (-0.17%)
BAC   26.32 (-1.53%)
BA   176.56 (+0.64%)
S&P 500   3,383.76 (+0.10%)
DOW   27,930.43 (-0.17%)
QQQ   274.36 (+0.92%)
AAPL   461.35 (+2.06%)
MSFT   210.71 (+0.73%)
FB   263.90 (+1.54%)
GOOGL   1,529.61 (+1.48%)
AMZN   3,207.98 (+1.45%)
NVDA   462.34 (+1.03%)
CGC   17.27 (+0.12%)
BABA   255.36 (+0.07%)
TSLA   1,639.00 (+5.42%)
GE   6.61 (-1.64%)
MU   46.79 (-3.49%)
AMD   82.50 (-0.13%)
T   29.97 (-0.70%)
F   7.10 (-0.14%)
ACB   10.00 (+2.04%)
GILD   68.06 (-1.13%)
NFLX   481.66 (+1.30%)
DIS   131.56 (-0.17%)
BAC   26.32 (-1.53%)
BA   176.56 (+0.64%)
S&P 500   3,383.76 (+0.10%)
DOW   27,930.43 (-0.17%)
QQQ   274.36 (+0.92%)
AAPL   461.35 (+2.06%)
MSFT   210.71 (+0.73%)
FB   263.90 (+1.54%)
GOOGL   1,529.61 (+1.48%)
AMZN   3,207.98 (+1.45%)
NVDA   462.34 (+1.03%)
CGC   17.27 (+0.12%)
BABA   255.36 (+0.07%)
TSLA   1,639.00 (+5.42%)
GE   6.61 (-1.64%)
MU   46.79 (-3.49%)
AMD   82.50 (-0.13%)
T   29.97 (-0.70%)
F   7.10 (-0.14%)
ACB   10.00 (+2.04%)
GILD   68.06 (-1.13%)
NFLX   481.66 (+1.30%)
DIS   131.56 (-0.17%)
BAC   26.32 (-1.53%)
BA   176.56 (+0.64%)
S&P 500   3,383.76 (+0.10%)
DOW   27,930.43 (-0.17%)
QQQ   274.36 (+0.92%)
AAPL   461.35 (+2.06%)
MSFT   210.71 (+0.73%)
FB   263.90 (+1.54%)
GOOGL   1,529.61 (+1.48%)
AMZN   3,207.98 (+1.45%)
NVDA   462.34 (+1.03%)
CGC   17.27 (+0.12%)
BABA   255.36 (+0.07%)
TSLA   1,639.00 (+5.42%)
GE   6.61 (-1.64%)
MU   46.79 (-3.49%)
AMD   82.50 (-0.13%)
T   29.97 (-0.70%)
F   7.10 (-0.14%)
ACB   10.00 (+2.04%)
GILD   68.06 (-1.13%)
NFLX   481.66 (+1.30%)
DIS   131.56 (-0.17%)
BAC   26.32 (-1.53%)
BA   176.56 (+0.64%)
Log in

NYSE:CLColgate-Palmolive Stock Price, Forecast & News

$76.98
-0.26 (-0.34 %)
(As of 08/13/2020 12:27 PM ET)
Add
Compare
Today's Range
$76.53
Now: $76.98
$77.15
50-Day Range
$71.52
MA: $74.48
$77.20
52-Week Range
$58.49
Now: $76.98
$77.78
Volume68,177 shs
Average Volume4.69 million shs
Market Capitalization$66.00 billion
P/E Ratio25.75
Dividend Yield2.32%
Beta0.61
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners. The company also provides home care products comprising dishwashing detergents, household cleaners, and fabric conditioners; pet nutrition products for everyday nutritional needs; and a range of therapeutic products to manage disease conditions in dogs and cats. Its principal global and regional trademarks include Colgate, Palmolive, elmex, Tom's of Maine, Sorriso, Speed Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sanex, Elta MD, PCA Skin, Ajax, Axion, Fabuloso, Soupline, and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. The company markets and sells its oral, personal, and home care products to various retailers, wholesalers, and distributors; and pet nutrition products for dogs and cats through pet supply retailers, veterinarians, and e-commerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
Read More
Colgate-Palmolive logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.2Community Rank: 1.8Dividend Strength: 4.2Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.88 out of 5 stars


Industry, Sector and Symbol

Industry Toilet preparations
Sub-IndustryHousehold Products
CUSIP19416210
Phone212-310-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$15.69 billion
Cash Flow$3.49 per share
Book Value$0.65 per share

Profitability

Net Income$2.37 billion

Miscellaneous

Employees34,300
Market Cap$66.00 billion
Next Earnings Date11/6/2020 (Estimated)
OptionableOptionable
$76.98
-0.26 (-0.34 %)
(As of 08/13/2020 12:27 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CL News and Ratings via Email

Sign-up to receive the latest news and ratings for CL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Colgate-Palmolive (NYSE:CL) Frequently Asked Questions

How has Colgate-Palmolive's stock been impacted by COVID-19?

Colgate-Palmolive's stock was trading at $68.90 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CL stock has increased by 11.8% and is now trading at $77.04.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Colgate-Palmolive?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There are currently 2 sell ratings, 4 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Colgate-Palmolive
.

When is Colgate-Palmolive's next earnings date?

Colgate-Palmolive is scheduled to release its next quarterly earnings announcement on Friday, November 6th 2020.
View our earnings forecast for Colgate-Palmolive
.

How were Colgate-Palmolive's earnings last quarter?

Colgate-Palmolive (NYSE:CL) released its quarterly earnings results on Friday, July, 31st. The company reported $0.74 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.69 by $0.05. The firm earned $3.90 billion during the quarter, compared to analysts' expectations of $3.78 billion. Colgate-Palmolive had a return on equity of 559.34% and a net margin of 16.13%. The business's quarterly revenue was up .8% on a year-over-year basis. During the same period in the previous year, the company posted $0.72 EPS.
View Colgate-Palmolive's earnings history
.

How often does Colgate-Palmolive pay dividends? What is the dividend yield for Colgate-Palmolive?

Colgate-Palmolive announced a quarterly dividend on Thursday, June 11th. Stockholders of record on Monday, July 20th will be given a dividend of $0.44 per share on Friday, August 14th. This represents a $1.76 dividend on an annualized basis and a yield of 2.28%. The ex-dividend date of this dividend is Friday, July 17th.
View Colgate-Palmolive's dividend history
.

What price target have analysts set for CL?

13 brokerages have issued 1 year price objectives for Colgate-Palmolive's shares. Their forecasts range from $58.00 to $88.00. On average, they anticipate Colgate-Palmolive's share price to reach $75.82 in the next twelve months. This suggests that the stock has a possible downside of 1.6%.
View analysts' price targets for Colgate-Palmolive
.

Has Colgate-Palmolive been receiving favorable news coverage?

News headlines about CL stock have been trending extremely negative on Thursday, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Colgate-Palmolive earned a coverage optimism score of -4.1 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the next few days.
View the latest news about Colgate-Palmolive
.

Who are some of Colgate-Palmolive's key competitors?

What other stocks do shareholders of Colgate-Palmolive own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Colgate-Palmolive investors own include Johnson & Johnson (JNJ), Procter & Gamble (PG), AT&T (T), AbbVie (ABBV), PepsiCo (PEP), Verizon Communications (VZ), Coca-Cola (KO), Intel (INTC), Mcdonald's (MCD) and Walmart (WMT).

Who are Colgate-Palmolive's key executives?

Colgate-Palmolive's management team includes the following people:
  • Mr. Ian M. Cook, Exec. Chairman (Age 66)
  • Mr. Noel R. Wallace, Pres, CEO & Director (Age 55)
  • Mr. Henning I. Jakobsen, Chief Financial Officer (Age 59)
  • Mr. P. Justin Skala, Exec. VP and Chief Growth & Strategy Officer (Age 59)
  • Dr. Patricia D. Verduin Ph.D., Chief Technology Officer (Age 60)

What is Colgate-Palmolive's stock symbol?

Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."

Who are Colgate-Palmolive's major shareholders?

Colgate-Palmolive's stock is owned by a number of retail and institutional investors. Top institutional investors include Bank of New York Mellon Corp (2.09%), First Eagle Investment Management LLC (1.46%), California Public Employees Retirement System (0.56%), Swiss National Bank (0.43%), Sumitomo Mitsui Trust Holdings Inc. (0.40%) and Sarasin & Partners LLP (0.39%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Dennis J Hickey, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, John W Kooyman, Justin Skala, Michael B Polk, Mukul Deoras, Noel R Wallace, Patricia Verduin, Philip G Shotts, Prabha Parameswaran and Stephen I Sadove.
View institutional ownership trends for Colgate-Palmolive
.

Which major investors are selling Colgate-Palmolive stock?

CL stock was sold by a variety of institutional investors in the last quarter, including Toronto Dominion Bank, AJO LP, Bank of New York Mellon Corp, ProShare Advisors LLC, Mondrian Investment Partners LTD, State of Tennessee Treasury Department, Victory Capital Management Inc., and Bank of Nova Scotia. Company insiders that have sold Colgate-Palmolive company stock in the last year include Daniel B Marsili, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John W Kooyman, Michael B Polk, Noel R Wallace, Patricia Verduin, Philip G Shotts, and Prabha Parameswaran.
View insider buying and selling activity for Colgate-Palmolive
.

Which major investors are buying Colgate-Palmolive stock?

CL stock was bought by a variety of institutional investors in the last quarter, including Nordea Investment Management AB, M&G Investment Management Ltd., Conning Inc., Sarasin & Partners LLP, CIBC Asset Management Inc, Prio Wealth Limited Partnership, California Public Employees Retirement System, and LGT Capital Partners LTD..
View insider buying and selling activity for Colgate-Palmolive
.

How do I buy shares of Colgate-Palmolive?

Shares of CL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Colgate-Palmolive's stock price today?

One share of CL stock can currently be purchased for approximately $77.04.

How big of a company is Colgate-Palmolive?

Colgate-Palmolive has a market capitalization of $66.05 billion and generates $15.69 billion in revenue each year. The company earns $2.37 billion in net income (profit) each year or $2.83 on an earnings per share basis. Colgate-Palmolive employs 34,300 workers across the globe.

What is Colgate-Palmolive's official website?

The official website for Colgate-Palmolive is www.colgatepalmolive.com.

How can I contact Colgate-Palmolive?

Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected]

This page was last updated on 8/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.